BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33298654)

  • 1. [Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease].
    Oya S; Yamasaki Y; Nakamura T; Morishige S; Yamaguchi M; Aoyama K; Seki R; Mouri H; Osaki K; Naito Y; Oshima K; Nagafuji K
    Rinsho Ketsueki; 2020; 61(11):1605-1610. PubMed ID: 33298654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease.
    Shiroshita K; Kikuchi T; Okayama M; Kasahara H; Kamiya T; Shimizu T; Kurose N; Masaki Y; Okamoto S
    Intern Med; 2020 Dec; 59(23):3061-3065. PubMed ID: 32759587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
    Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
    Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline Case of TAFRO Syndrome and POEMS Syndrome.
    Shibata S; Tabata S; Morita H; Endo T; Kawasaki N; Okamoto Y; Inano S; Takiuchi Y; Fukunaga A; Kitano T
    Intern Med; 2021 May; 60(10):1589-1595. PubMed ID: 33328401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6-producing giant cell carcinoma of the lung with multicentric Castleman's disease-like presentation.
    Higashikuni Y; Mori M; Kino H
    Intern Med; 2007; 46(10):669-73. PubMed ID: 17527041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Doai M; Matoba M; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Mizumaki H; Yamaguchi M; Masaki Y
    Intern Med; 2019 Sep; 58(17):2555-2560. PubMed ID: 31178507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric IL-5-positive Castleman Disease With Nephrotic Syndrome Relapsed After Rituximab Treatment.
    Mima A; Lee R; Murakami A; Gotoda H; Akai R; Lee S
    In Vivo; 2023; 37(1):493-497. PubMed ID: 36593046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AA amyloidosis associated with Castleman disease: A case report and review of the literature.
    Bernabei L; Waxman A; Caponetti G; Fajgenbaum DC; Weiss BM
    Medicine (Baltimore); 2020 Feb; 99(6):e18978. PubMed ID: 32028407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Interleukin-6 in Castleman Disease.
    Yoshizaki K; Murayama S; Ito H; Koga T
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):23-36. PubMed ID: 29157617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice.
    Yamazaki Y; Yoshida Y; Shimizu M; Kobayashi T; Tojima H; Sato K; Kakizaki S; Handa H; Yokoo H; Uraoka T
    Intern Med; 2021 Nov; 60(22):3615-3620. PubMed ID: 34092729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evans syndrome complicated with multicentric Castleman disease successfully treated with tocilizumab].
    Nakayama H; Kikuchi T; Abe R; Tozawa K; Watanuki S; Shimizu T; Mitsuhashi T; Murata M; Okamoto S; Mori T
    Rinsho Ketsueki; 2018; 59(8):997-1001. PubMed ID: 30185717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
    Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-6-producing dermoid cyst associated with multicentric Castleman's disease.
    Ebara S; Song SN; Mizuta H; Ito Y; Hasegawa K; Kamata T; Matsumura-Nishikawa T; Ogawa T; Soneda J; Yoshizaki K
    Int J Hematol; 2012 Feb; 95(2):198-203. PubMed ID: 22167657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
    Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
    J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels.
    Ikeura T; Horitani S; Masuda M; Kasai T; Yanagawa M; Miyoshi H; Uchida K; Takaoka M; Miyasaka C; Uemura Y; Okazaki K
    Intern Med; 2016; 55(18):2623-8. PubMed ID: 27629957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of Castleman disease.
    Soumerai JD; Sohani AR; Abramson JS
    Cancer Control; 2014 Oct; 21(4):266-78. PubMed ID: 25310208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan.
    Murakami M; Johkoh T; Hayashi S; Ohshima S; Mizuki M; Nakatsuka SI; Tomobe M; Kuroyanagi K; Nakasone A; Nishimoto N
    Mod Rheumatol; 2020 Sep; 30(5):843-851. PubMed ID: 31829070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.